Cargando…
Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
INTRODUCTION: Ductal carcinoma in situ (DCIS) of the breast is a non-obligate precursor of invasive breast cancer (IBC). Many DCIS patients are either undertreated or overtreated. The overarching goal of the study described here is to facilitate detection of patients with DCIS at risk of IBC develop...
Autores principales: | Rohan, Thomas E, Ginsberg, Mindy, Wang, Yihong, Couch, Fergus J, Feigelson, Heather S, Greenlee, Robert T, Honda, Stacey, Stark, Azadeh, Chitale, Dhananjay, Wang, Tao, Xue, Xiaonan, Oktay, Maja H, Sparano, Joseph A, Loudig, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549665/ https://www.ncbi.nlm.nih.gov/pubmed/34702732 http://dx.doi.org/10.1136/bmjopen-2021-053397 |
Ejemplares similares
-
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens
por: Loudig, Olivier, et al.
Publicado: (2017) -
MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer
por: Rohan, Thomas, et al.
Publicado: (2018) -
Somatic mutations in benign breast disease tissue and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2018) -
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016) -
Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer
por: Rohan, Thomas E., et al.
Publicado: (2021)